Literature DB >> 26681906

Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

George DeMaagd, Ashok Philip.   

Abstract

Most patients with Parkinson's disease experience nonmotor complications, broadly classified as either neuropsychiatric presentations or autonomic disorders. Despite the prevalence of these nonmotor features, treatment options for them are limited.

Entities:  

Year:  2015        PMID： 26681906      PMCID： PMC4671469     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  136 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.

Authors:  Dan A Mendonça; Krishe Menezes; Mandar S Jog
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

3.  Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.

Authors:  William G Ondo; Ron Tintner; Kevin Dat Voung; Dejian Lai; George Ringholz
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

4.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 5.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

6.  Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.

Authors:  Frederick A Schmitt; Dag Aarsland; Kolbjørn S Brønnick; Xiangyi Meng; Sibel Tekin; Jason T Olin
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-04-14       Impact factor: 2.035

7.  Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Authors:  Frédéric Courbon; Christine Brefel-Courbon; Claire Thalamas; Marie-Jeanne Alibelli; Isabelle Berry; Jean-Louis Montastruc; Olivier Rascol; Jean-Michel Senard
Journal:  Mov Disord       Date:  2003-08       Impact factor: 10.338

8.  Prevalence of smell loss in Parkinson's disease--a multicenter study.

Authors:  A Haehner; S Boesveldt; H W Berendse; A Mackay-Sim; J Fleischmann; P A Silburn; A N Johnston; G D Mellick; B Herting; H Reichmann; T Hummel
Journal:  Parkinsonism Relat Disord       Date:  2009-01-11       Impact factor: 4.891

9.  Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.

Authors:  Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Riboldazzi; Daniela Calandrella; Gabriele Brunetti; Claudio Pacchetti
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

10.  Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Authors:  Sara Hall; Annika Öhrfelt; Radu Constantinescu; Ulf Andreasson; Yulia Surova; Frederick Bostrom; Christer Nilsson; Widner Håkan; Hilde Decraemer; Katarina Någga; Lennart Minthon; Elisabet Londos; Eugeen Vanmechelen; Björn Holmberg; Henrik Zetterberg; Kaj Blennow; Oskar Hansson
Journal:  Arch Neurol       Date:  2012-11
View more
  2 in total

1.  A novel yeast-based screening system for potential compounds that can alleviate human α-synuclein toxicity.

Authors:  Anyaporn Sangkaew; Thanaporn Kojornna; Ryoya Tanahashi; Hiroshi Takagi; Chulee Yompakdee
Journal:  J Appl Microbiol       Date:  2021-08-31       Impact factor: 4.059

Review 2.  Four main therapeutic keys for Parkinson's disease: A mini review.

Authors:  Daniel Hernandez-Baltazar; Rasajna Nadella; Laura Mireya Zavala-Flores; Christian de Jesús Rosas-Jarquin; María de Jesús Rovirosa-Hernandez; Arnulfo Villanueva-Olivo
Journal:  Iran J Basic Med Sci       Date:  2019-07       Impact factor: 2.699
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.